Find Bismuth Potassium Citrate manufacturers, exporters & distributors on PharmaCompass

bismuth subcitrate

Synopsis, Chemistry

APIs // Active Pharmaceutical Ingredients

5 API Suppliers, 2 USDMF, 5 KDMF, 3 Listed Suppliers

DEVELOPMENTS

2 Drug(s) in Development

2 Drug(s) in Development

DOSSIERs // Finished Dosage Formulations

2 Dossiers, 1 Europe, 1 South Africa

MARKET PLACE

6 APIs

6 APIs

API SUPPLIERS

API Suppliers

US DMFs Filed

CEP/COS Certifications

JDMFs Filed

Other Certificates

Other Suppliers

API REF. PRICE (USD / KG)

API Market Place

INTERMEDIATES

DOSSIERS // FDF

USA (Orange Book)

Europe

Canada

Australia

South Africa

Uploaded Dossiers

GLOBAL SALES (USD Million)

U.S. Medicaid

Annual Reports

FDF Market Place

EXCIPIENTS

PATENTS & EXCLUSIVITIES

USFDA Orange Book Patents

USFDA Exclusivities

DIGITAL CONTENT

Blog #PharmaFlow

News

REF STANDARD

EDQM

USP

Other Listed Suppliers

SERVICES

Also known as: Gastrodenol, Bismuth tripotassium dicitrate, 57644-54-9, Colloidal bismuth subcitrate, Tripotassium dicitratobismuthate, Hs813p8qpx

Molecular Formula

C₁₂H₁₀BiK₃O₁₄

Molecular Weight

704.47 g/mol

InChI Key

ZQUAVILLCXTKTF-UHFFFAOYSA-H

FDA UNII

HS813P8QPX

Bismuth Subcitrate is a mineral compound that is used to treat duodenal and gastric ulcers associated with Helicobacter pylori.

1 2D Structure

bismuth subcitrate

2 Identification

2.1 Computed Descriptors

2.1.1 IUPAC Name

bismuth;tripotassium;2-hydroxypropane-1,2,3-tricarboxylate

2.1.2 InChI

InChI=1S/2C6H8O7.Bi.3K/c2*7-3(8)1-6(13,5(11)12)2-4(9)10;;;;/h2*13H,1-2H2,(H,7,8)(H,9,10)(H,11,12);;;;/q;;+3;3*+1/p-6

2.1.3 InChI Key

ZQUAVILLCXTKTF-UHFFFAOYSA-H

2.1.4 Canonical SMILES

C(C(=O)[O-])C(CC(=O)[O-])(C(=O)[O-])O.C(C(=O)[O-])C(CC(=O)[O-])(C(=O)[O-])O.[K+].[K+].[K+].[Bi+3]

2.2 Other Identifiers

2.2.1 UNII

HS813P8QPX

2.3 Synonyms

2.3.1 MeSH Synonyms

1. Bi-citrate

2. Biselic

3. Bismofarma

4. Bismuth Citrate

5. Bismuth Tripotassium Dicitrate

6. Colloidal Bismuth Subcitrate

7. De-nol

8. De-noltab

9. Denol

10. Gastrodenol

11. Sucrato

12. Tripotassium-dicitrato Bismuthate

13. Ventrisol-polfa

2.3.2 Depositor-Supplied Synonyms

1. Gastrodenol

2. Bismuth Tripotassium Dicitrate

3. 57644-54-9

4. Colloidal Bismuth Subcitrate

5. Tripotassium Dicitratobismuthate

6. Hs813p8qpx

7. Bismuth;tripotassium;2-hydroxypropane-1,2,3-tricarboxylate

8. Bismuth Subcitrate Potassium

9. De-noltab

10. 1,2,3-propanetricarboxylic Acid, 2-hydroxy-, Bismuth(3+) Potassium Salt (2:1:3)

11. Tripotassium;2-hydroxypropane-1,2,3-tricarboxylate;5-hydroxy-2,8,9-trioxa-1-bismabicyclo[3.3.2]decane-3,7,10-trione

12. Unii-hs813p8qpx

13. Einecs 260-872-5

14. De-nol (tn)

15. Tripotassium Dicitrate Bismuthate

16. Bismuth Subcitrate [vandf]

17. Bcp10508

18. Bismuth Subcitrate [who-dd]

19. Hy-b0796

20. Bismuth Subcitrate, Colloidal

21. Mfcd02101411

22. Akos005110988

23. Cs-3966

24. Colloidal Bismuth Subcitrate [mi]

25. B4377

26. Ft-0623129

27. D07587

28. Tripotassium Dicitratobismuthate [who-dd]

29. Bismuth(iii) Tripotassium 2-hydroxypropane-1,2,3-tricarboxylate

30. Bismuth(3+) Tripotassium Bis(2-hydroxypropane-1,2,3-tricarboxylate)

31. Bismuth Tripotassium Dicitrate; Bismuth Subcitrate; Duosol; Gastrodenol; Bismuth Subcitrate Potassium; De-nol

2.4 Create Date

2006-10-25

3 Chemical and Physical Properties

Molecular Formula	C₁₂H₁₀BiK₃O₁₄
Molecular Weight	704.47 g/mol
Hydrogen Bond Donor Count	2
Hydrogen Bond Acceptor Count	14
Rotatable Bond Count	4
Exact Mass	703.87857 g/mol
Monoisotopic Mass	703.87857 g/mol
Topological Polar Surface Area	281 Å²
Heavy Atom Count	30
Formal Charge	0
Complexity	211
Isotope Atom Count	0
Defined Atom Stereocenter Count	0
Undefined Atom Stereocenter Count	0
Defined Bond Stereocenter Count	0
Undefined Bond Stereocenter Count	0
Covalently Bonded Unit Count	6

4 Pharmacology and Biochemistry

4.1 MeSH Pharmacological Classification

Antacids

Substances that counteract or neutralize acidity of the GASTROINTESTINAL TRACT. (See all compounds classified as Antacids.)

Anti-Infective Agents

Substances that prevent infectious agents or organisms from spreading or kill infectious agents in order to prevent the spread of infection. (See all compounds classified as Anti-Infective Agents.)

Anti-Ulcer Agents

Various agents with different action mechanisms used to treat or ameliorate PEPTIC ULCER or irritation of the gastrointestinal tract. This has included ANTIBIOTICS to treat HELICOBACTER INFECTIONS; HISTAMINE H2 ANTAGONISTS to reduce GASTRIC ACID secretion; and ANTACIDS for symptomatic relief. (See all compounds classified as Anti-Ulcer Agents.)

4.2 ATC Code

A - Alimentary tract and metabolism

A02 - Drugs for acid related disorders

A02B - Drugs for peptic ulcer and gastro-oesophageal reflux disease (gord)

A02BX - Other drugs for peptic ulcer and gastro-oesophageal reflux disease (gord)

A02BX05 - Bismuth subcitrate